Last reviewed · How we verify
NCT06645873: CGM-IC
Exploration of Continuous Glucose Monitoring on the Intensive Care Unit
NA trial testing Continuous glucose monitoring (CGM) device in Hypoglycemia, Hyperglycemia in 100 participants. Completed in 30 September 2025.
30 September 2025
Quick facts
| Lead sponsor | Kim Kamphorst |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 100 |
| Start date | 17 December 2024 |
| Primary completion | 30 September 2025 |
| Estimated completion | 30 September 2025 |
| Sites | 3 locations across Netherlands |
Drugs / interventions tested
- Continuous glucose monitoring (CGM) device
Conditions studied
- Hypoglycemia, Hyperglycemia — all drugs for Hypoglycemia, Hyperglycemia →
Sponsor
Kim Kamphorst
Who can join
18 and older, any sex, with Hypoglycemia, Hyperglycemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Both hyperglycemia and hypoglycemia in patients at the intensive care unit (ICU) are strongly associated with increased morbidity and mortality. Accurate and timely measurements of glucose levels in this population are therefore crucial. Continuous glucose monitoring (CGM) appears promising for this purpose, but it is not yet used in the ICU due to insufficient knowledge about its reliability in critically ill patients. The aim of this study is to investigate the discrepancy between CGM and point-of-care measurements in ICU patients and whether this discrepancy is consistent across all ICU patient groups/characteristics. This study investigates whether continuous glucose monitoring can be used in the intensive care setting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06645873
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Continuous glucose monitoring (CGM) device
Trials testing the same drug.
- NCT06331923 — Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients with Diabetes · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06645873 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kim Kamphorst
- Last refreshed: 3 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06645873.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing